Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)

被引：4
|
作者：
Trigo, J. [1 ]
Cho, B. C. [2 ]
Park, K. [3 ]
Girard, N. [4 ]
Viteri, S. [5 ]
Garrido, P. [6 ]
Krebs, M. G. [7 ,8 ]
Thayu, M. [9 ]
Knoblauch, R. E. [9 ]
Xie, J. [9 ]
Bauml, J. M. [9 ]
Schnepp, R. W. [9 ]
Londhe, A. [9 ]
Mahadevia, P. [9 ]
Leighl, N. [10 ]
机构：
[1] Hosp Univ Virgen Victoria & Reg, IBIMA, Malaga, Spain
[2] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Inst Curie, Thorax Inst, Paris, France
[5] UOMI Canc Ctr, Clin Mi Tres Torres, Barcelona, Spain
[6] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain
[7] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
[8] Christie NHS Fdn Trust, Manchester Acad, Hlth Sci Ctr, Manchester, Lancs, England
[9] Janssen R&D, Spring House, PA USA
[10] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20P
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [1] Amivantamab: Prolonged Survivor in Post-TKI NSCLC with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutation (ex20ins)
    Aguilar, A.
    Cao, M. Gonzalez
    de las Casas, C. Mayo
    Molina, M. A.
    Esteban, C. Aguado
    Barrera, J. Bosch
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S648 - S648
  • [2] Epidermal growth factor receptor (EGFR) testing and treatment patterns associated with diagnosis of non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions (ex20ins) in the US
    Piotrowska, Z.
    Lin, M.
    Yin, Y.
    Curran, E.
    Crossland, V.
    Wu, Y.
    Ou, S-H. I.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1011 - S1011
  • [3] CUTANEOUS TOXICITIES WITH AMIVANTAMAB FOR NON-SMALL CELL LUNG CANCER ( NSCLC) WITH EXON 20 INSERTION MUTATION (EX20INS): A PRACTICAL GUIDE AND BEST PRACTICES FOR MANAGEMENT
    Singh-Kandah, Shahnaz
    Wang, Kaiwen
    Xia, Karen
    Johnson, Andy
    D'Andrea, Denise
    Dougherty, Lindsay
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [4] Epidermal growth factor receptor (EGFR) mutation testing and immunotherapy (IO) use associated with diagnosis of non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions (ex20ins) in the US
    Ou, S-H. I.
    Lin, M.
    Yin, Y.
    Curran, E.
    Churchill, E.
    Piotrowska, Z.
    ANNALS OF ONCOLOGY, 2022, 33 : S1581 - S1581
  • [5] Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis
    Girard, N.
    Park, K.
    Viteri, S.
    Schioppa, C. A.
    Diels, J.
    Oguz, M.
    Rodrigues, B. H.
    Rahhali, N.
    Sermon, J.
    Ghilotti, F.
    Li, T.
    Knoblauch, R. E.
    Mahadevia, P.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2022, 33 : S38 - S38
  • [6] PRACTICAL GUIDE FOR INFUSION-RELATED REACTION (IRR) MANAGEMENT WITH AMIVANTAMAB FOR EXON 20 INSERTION MUTATION (EX20INS) NON-SMALL CELL LUNG CANCER (NSCLC): A NURSE'S VIEW
    Dougherty, Lindsay
    Bhaumik, Amitabha
    D'Andrea, Denise
    Johnson, Andy
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : 20 - 21
  • [7] Matching-adjusted indirect comparison (MAIC) of mobocertinib versus amivantamab in patients with non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions (ex20ins).
    Ou, Sai-Hong Ignatius
    Prawitz, Thibaud
    Lin, Huamao Mark
    Hong, Jin-Liern
    Tan, Minal
    Proskorovsky, Irina
    Hernandez, Luis
    Jin, Shu
    Zhang, Pingkuan
    Lin, Jianchang
    Patel, Jyoti D.
    Nguyen, Danny
    Neal, Joel W.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).
    Park, Keunchil
    John, Thomas
    Kim, Sang-We
    Lee, Jong Seok
    Shu, Catherine A.
    Kim, Dong-Wan
    Ramirez, Santiago Viteri
    Spira, Alexander, I
    Sabari, Joshua K.
    Han, Ji-Youn
    Trigo, Jose Manuel
    Lee, Chee Khoon
    Lee, Ki Hyeong
    Girard, Nicolas
    Lorenzini, Patricia A.
    Xie, John
    Roshak, Amy
    Thayu, Meena
    Knoblauch, Roland Elmar
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Real-world frequency of non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations by site of insertion
    Viteri, S.
    Bauml, J. M.
    Bazhenova, L.
    Ou, S-H. I.
    Girard, N.
    Schaffer, M.
    Rose, J.
    Curtin, J.
    Karkera, J.
    Mahadevia, P.
    Minchom, A. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S699 - S699
  • [10] Real-World Treatment Outcomes of Amivantamab in Pre-Approval Access (PAA) Participants with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutations (ex20ins)
    Sabari, J.
    Kim, T. M.
    Spira, A.
    Lee, S. H.
    Chang, G. C.
    Shih, J. -Y.
    Hochmair, M. J.
    Schioppa, C. A.
    Schioppa, C. A.
    Panaccione, A.
    Rose, J. B.
    Chioda, M.
    Mahadevia, P.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E23 - E23
12345